Literature DB >> 33604323

Joint Investigation of 2-Month Post-diagnosis IgG Antibody Levels and Psychological Measures for Assessing Longer Term Multi-Faceted Recovery Among COVID-19 Cases in Northern Cyprus.

Burc Barin1, Banu Elcin Yoldascan2, Fatma Savaskan3, Goncagul Ozbalikci4, Tugce Karaderi5,6,7, Hüseyin Çakal8.   

Abstract

Following the outbreak of COVID-19, multidisciplinary research focusing on the long-term effects of the COVID-19 infection and the complete recovery is still scarce. With regards to long-term consequences, biomarkers of physiological effects as well as the psychological experiences are of significant importance for comprehensively understanding the complete COVID-19 recovery. The present research surveys the IgG antibody titers and the impact of COVID-19 as a traumatic experience in the aftermath of the active infection period, around 2 months after diagnosis, in a subset of COVID-19 patients from the first wave (March-April 2020) of the outbreak in Northern Cyprus. Associations of antibody titers and psychological survey measures with baseline characteristics and disease severity were explored, and correlations among various measures were evaluated. Of the 47 serology tests conducted for presence of IgG antibodies, 39 (83%) were positive. We identified trends demonstrating individuals experiencing severe or critical COVID-19 disease and/or those with comorbidities are more heavily impacted both physiologically and mentally, with higher IgG titers and negative psychological experience compared to those with milder disease and without comorbidities. We also observed that more than half of the COVID-19 cases had negative psychological experiences, being subjected to discrimination and verbal harassment/insult, by family/friends. In summary, as the first study co-evaluating immune response together with mental status in COVID-19, our findings suggest that further multidisciplinary research in larger sample populations as well as community intervention plans are needed to holistically address the physiological and psychological effects of COVID-19 among the cases.
Copyright © 2021 Barin, Yoldascan, Savaskan, Ozbalikci, Karaderi and Çakal.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; antibody; immune response; long COVID; psychological impact; recovery; stigma

Year:  2021        PMID: 33604323      PMCID: PMC7884822          DOI: 10.3389/fpubh.2020.590096

Source DB:  PubMed          Journal:  Front Public Health        ISSN: 2296-2565


  21 in total

1.  Long-term Health Consequences of COVID-19.

Authors:  Carlos Del Rio; Lauren F Collins; Preeti Malani
Journal:  JAMA       Date:  2020-11-03       Impact factor: 56.272

2.  Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry.

Authors:  Suzanne C Segerstrom; Gregory E Miller
Journal:  Psychol Bull       Date:  2004-07       Impact factor: 17.737

3.  The psychological impact of the SARS epidemic on hospital employees in China: exposure, risk perception, and altruistic acceptance of risk.

Authors:  Ping Wu; Yunyun Fang; Zhiqiang Guan; Bin Fan; Junhui Kong; Zhongling Yao; Xinhua Liu; Cordelia J Fuller; Ezra Susser; Jin Lu; Christina W Hoven
Journal:  Can J Psychiatry       Date:  2009-05       Impact factor: 4.356

4.  The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital.

Authors:  Robert Maunder; Jonathan Hunter; Leslie Vincent; Jocelyn Bennett; Nathalie Peladeau; Molyn Leszcz; Joel Sadavoy; Lieve M Verhaeghe; Rosalie Steinberg; Tony Mazzulli
Journal:  CMAJ       Date:  2003-05-13       Impact factor: 8.262

5.  Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.

Authors:  Chuan Qin; Luoqi Zhou; Ziwei Hu; Shuoqi Zhang; Sheng Yang; Yu Tao; Cuihong Xie; Ke Ma; Ke Shang; Wei Wang; Dai-Shi Tian
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

6.  Long COVID: let patients help define long-lasting COVID symptoms.

Authors: 
Journal:  Nature       Date:  2020-10       Impact factor: 49.962

7.  Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.

Authors:  Andrew Bryan; Gregory Pepper; Mark H Wener; Susan L Fink; Chihiro Morishima; Anu Chaudhary; Keith R Jerome; Patrick C Mathias; Alexander L Greninger
Journal:  J Clin Microbiol       Date:  2020-07-23       Impact factor: 5.948

Review 8.  Psychosocial impact of COVID-19.

Authors:  Souvik Dubey; Payel Biswas; Ritwik Ghosh; Subhankar Chatterjee; Mahua Jana Dubey; Subham Chatterjee; Durjoy Lahiri; Carl J Lavie
Journal:  Diabetes Metab Syndr       Date:  2020-05-27

9.  Detection of IgM and IgG antibodies in patients with coronavirus disease 2019.

Authors:  Hongyan Hou; Ting Wang; Bo Zhang; Ying Luo; Lie Mao; Feng Wang; Shiji Wu; Ziyong Sun
Journal:  Clin Transl Immunology       Date:  2020-05-06

10.  Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China.

Authors:  Hai-Xin Bo; Wen Li; Yuan Yang; Yu Wang; Qinge Zhang; Teris Cheung; Xinjuan Wu; Yu-Tao Xiang
Journal:  Psychol Med       Date:  2020-03-27       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.